Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of malignant lymphomas].

H Huber, C Gattringer, M Lechleitner

    Wiener Klinische Wochenschrift
    |February 18, 1983
    PubMed
    Summary

    Prognostic factors guide treatment for Hodgkin's disease and non-Hodgkin lymphomas. Tailored therapeutic approaches based on disease type, grade, and stage improve patient outcomes and survival chances.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.

    Leukemia & lymphoma·2016
    Same author

    Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.

    British journal of cancer·2005
    Same author

    Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.

    Leukemia·2004
    Same author

    [Chronic lymphatic leukemia. Current therapy concepts].

    Der Internist·2003
    Same author

    Transcription of AML1 in hematopoietic subfractions of normal adults.

    Annals of hematology·2002
    Same author

    Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.

    Annals of hematology·2002

    Area of Science:

    • Oncology
    • Hematology

    Context:

    • Review of prognostic factors in Hodgkin's disease and non-Hodgkin lymphomas.
    • Basis for therapeutic approach in these hematologic malignancies.

    Purpose:

    • To review and discuss prognostic factors for Hodgkin's disease and non-Hodgkin lymphomas.
    • To outline therapeutic strategies based on these factors.

    Summary:

    • Hodgkin's disease treatment is based on stage, histology, and prognostic criteria.
    • Non-Hodgkin lymphomas are classified by grade (low, intermediate, high) using the Kiel classification, dictating distinct treatment modalities.
    • Management strategies for low- and high-grade lymphomas are summarized based on disease stage.

    Impact:

    • Informs clinical decision-making for optimal patient management.
    • Highlights the importance of accurate classification and staging for treatment efficacy.
    • Discusses chances of cure and recent developments in lymphoma treatment.

    Related Experiment Videos